Explaining the unexpected COVID-19 trends and potential impact across Africa.


Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2021
Historique:
accepted: 16 09 2022
entrez: 9 1 2023
pubmed: 22 11 2021
medline: 11 1 2023
Statut: epublish

Résumé

Official COVID-19 case counts and mortality rates across Africa are lower than had been anticipated. Research reports, however, indicate far higher exposure rates than the official counts in some countries. Particularly in Western and Central Africa, where mortality rates are disproportionately lower than the rest of the continent, this occurrence may be due to immune response adaptations resulting from (1) frequent exposure to certain pro-inflammatory pathogens, and (2) a prevalence of low-grade inflammation coupled with peculiar modifications to the immune response based on one's immunobiography. We suggest that the two factors lead to a situation where post infection, there is a rapid ramp-up of innate immune responses, enough to induce effective defense and protection against plethora pathogens. Alongside current efforts at procuring and distributing vaccines, we draw attention to the need for work towards appreciating the impact of the apparently widespread, asymptomatic SARS-CoV-2 infections on Africa's populations

Identifiants

pubmed: 36605410
doi: 10.12688/f1000research.74363.2
pmc: PMC9763772.2
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1177

Subventions

Organisme : Medical Research Council
ID : MR/P028071/1
Pays : United Kingdom

Informations de copyright

Copyright: © 2022 Oduro-Mensah D et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

PLoS One. 2020 Dec 16;15(12):e0243888
pubmed: 33326480
Front Immunol. 2019 May 10;10:1071
pubmed: 31134099
BMC Public Health. 2022 Sep 5;22(1):1676
pubmed: 36064368
Front Immunol. 2018 Sep 20;9:2128
pubmed: 30298071
Science. 2020 Aug 7;369(6504):624-626
pubmed: 32764055
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Mech Ageing Dev. 2014 Jul;139:49-57
pubmed: 25011077
Int J Infect Dis. 2020 Oct;99:437-440
pubmed: 32805422
Environ Int. 2021 Nov;156:106695
pubmed: 34171587
Global Health. 2010 Apr 19;6:5
pubmed: 20403167
J Clin Med. 2020 Apr 16;9(4):
pubmed: 32316118
Am J Trop Med Hyg. 2020 Aug;103(2):564-569
pubmed: 32484156
Curr Mol Med. 2006 Mar;6(2):205-21
pubmed: 16515511
Exp Gerontol. 2004 May;39(5):687-99
pubmed: 15130663
PLoS One. 2013;8(2):e55756
pubmed: 23437061
Malar J. 2012 Apr 05;11:109
pubmed: 22480186
Int J Obes (Lond). 2021 Mar;45(3):687-694
pubmed: 33495522
Front Immunol. 2020 Jul 14;11:1762
pubmed: 32760408
Lancet Microbe. 2020 Aug;1(4):e151
pubmed: 33521716
BMJ Nutr Prev Health. 2022 Jan 19;5(1):10-18
pubmed: 35814718
Popul Health Metr. 2020 Sep 30;18(Suppl 1):5
pubmed: 32993671
Eur J Med Res. 2020 Dec 2;25(1):64
pubmed: 33267871
Brain Behav Immun. 2016 Nov;58:63-68
pubmed: 27223095
Front Neurol. 2019 May 29;10:533
pubmed: 31191433
J Med Virol. 2021 May;93(5):2662-2674
pubmed: 33200825
Emerg Microbes Infect. 2021 Dec;10(1):664-676
pubmed: 33734013
Lancet. 2021 May 22;397(10288):1885-1894
pubmed: 34022988
Sci Immunol. 2021 Nov 12;6(65):eabk1741
pubmed: 34591653
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Science. 2020 Jul 17;369(6501):256-257
pubmed: 32675364
Front Immunol. 2018 Mar 01;9:339
pubmed: 29545794
Ageing Res Rev. 2017 Nov;40:95-119
pubmed: 28899766
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Rev Med Virol. 2022 Mar;32(2):e2271
pubmed: 34228851
Thorax. 2021 Apr;76(4):405-407
pubmed: 33273028
Front Cardiovasc Med. 2018 Feb 22;5:12
pubmed: 29564335
Glob Health Sci Pract. 2021 Sep 30;9(3):433-443
pubmed: 34593571
Br J Nutr. 2015 Oct 14;114(7):999-1012
pubmed: 26228057
Cell Mol Immunol. 2020 Sep;17(9):998-1000
pubmed: 32728199
Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S406-S409
pubmed: 29161078
Endocrinology. 2020 Nov 1;161(11):
pubmed: 32880654
Virulence. 2020 Dec;11(1):1006-1014
pubmed: 32722990
Malar J. 2017 Apr 11;16(1):145
pubmed: 28399920
Sci Rep. 2021 Jan 26;11(1):2256
pubmed: 33500431
Obes Facts. 2020;13(4):430-438
pubmed: 32659766
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
pubmed: 19136431
BMC Geriatr. 2021 Jan 15;21(1):63
pubmed: 33451296
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Science. 2022 Jan 28;375(6579):364-366
pubmed: 35084966
Ann Intern Med. 2021 Apr;174(4):576-578
pubmed: 33175566
Cir Cir. 2015 Nov-Dec;83(6):543-51
pubmed: 26159364
Sci Rep. 2021 Mar 30;11(1):7193
pubmed: 33785830
Front Immunol. 2014 Apr 09;5:153
pubmed: 24782860
Trends Microbiol. 2021 Nov;29(11):973-982
pubmed: 33757684
Nat Commun. 2021 Jun 25;12(1):3966
pubmed: 34172732
Clin Infect Dis. 2008 Dec 1;47(11):1380-7
pubmed: 18947328
Ghana Med J. 2012 Jun;46(2 Suppl):1-3
pubmed: 23661810
Curr Pharm Des. 2013;19(9):1675-9
pubmed: 23589904
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Mech Ageing Dev. 2007 Jan;128(1):92-105
pubmed: 17116321
N Engl J Med. 2020 Dec 17;383(25):2427-2438
pubmed: 32991794
Respir Med Case Rep. 2021;33:101314
pubmed: 33312856
Front Immunol. 2020 Oct 08;11:574910
pubmed: 33117371
Int J Infect Dis. 2021 Jan;102:577-583
pubmed: 33176202
Int J Obes (Lond). 2020 Aug;44(8):1790-1792
pubmed: 32409680
Semin Immunopathol. 2017 Nov;39(6):643-652
pubmed: 28685270
Malar J. 2017 Dec 29;16(1):499
pubmed: 29284469
Lancet. 2021 Dec 19;396(10267):1979-1993
pubmed: 33220855
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Kidney Blood Press Res. 2021;46(1):126-134
pubmed: 33503627
BMC Infect Dis. 2021 Jan 18;21(1):78
pubmed: 33461499
Nat Commun. 2020 Jul 30;11(1):3810
pubmed: 32733001
Clin Microbiol Infect. 2021 Feb 16;:
pubmed: 33607252
J Immunol. 2010 Mar 1;184(5):2518-27
pubmed: 20100933
AAS Open Res. 2021 Jan 13;4:2
pubmed: 34729457
BMC Health Serv Res. 2020 Dec 20;20(1):1144
pubmed: 33342437
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Virol J. 2022 Jun 5;19(1):100
pubmed: 35659687
BMC Med. 2022 Jan 14;20(1):26
pubmed: 35027067
Sci Transl Med. 2014 Aug 27;6(251):251ra117
pubmed: 25163477
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Front Immunol. 2018 Oct 16;9:2135
pubmed: 30386324
PLoS Pathog. 2014 Apr 17;10(4):e1004079
pubmed: 24743880
PLoS One. 2016 Oct 27;11(10):e0165533
pubmed: 27788241
Int J Obes (Lond). 2020 Jul;44(7):1541-1542
pubmed: 32444771

Auteurs

Daniel Oduro-Mensah (D)

Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.

Ebenezer Oduro-Mensah (E)

Ga-East Municipal Hospital, Ghana Health Service, Accra, WY1895, Ghana.

Peter Quashie (P)

West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, LG 581, Ghana.

Gordon Awandare (G)

Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.

Laud Okine (L)

Department of Biochemistry, Cell and Molecular Biology, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
West African Center for Cell Biology of Infectious Pathogens, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH